Neuropathology of synuclein aggregates

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alpha-synuclein (alpha-syn) is implicated in neurodegenerative diseases, termed synucleinopathies.
• Abnormal alpha-syn is linked to Parkinson's disease (PD), dementia with Lewy bodies (DLB), and Alzheimer's disease (AD).
• Alpha-syn aggregates form lesions in various neurodegenerative conditions, including multiple system atrophy.

Purpose of the Study:

• To explore the role of alpha-synuclein in neurodegenerative disease pathogenesis.
• To investigate the aggregation and fibrillogenesis of alpha-synuclein.
• To highlight the importance of understanding synuclein aggregation for therapeutic development.

Main Methods:

• Isolation of the non-Abeta component of amyloid plaques (NAC peptide) from Alzheimer's disease brains.
• Genetic studies identifying pathogenic mutations in the alpha-synuclein gene.
• In vitro studies examining the aggregation and fibrillogenesis of mutant and wild-type alpha-synuclein.

Main Results:

• Alpha-synuclein is a major component of Lewy bodies and glial cytoplasmic inclusions in synucleinopathies.
• Mutations in the alpha-synuclein gene are linked to familial Parkinson's disease.
• In vitro studies confirm alpha-synuclein's propensity for aggregation and fibril formation.

Conclusions:

• Alpha-synuclein aggregation is a common pathogenic mechanism in diverse neurodegenerative diseases.
• Clarifying synuclein aggregation mechanisms is crucial for developing effective treatments.
• Beta- and gamma-synuclein also play roles in neurodegeneration, expanding the scope of synucleinopathies.